NICE guideline NG155: Tinnitus — assessment and management

Record details

• Authors: National Institute for Health and Care Excellence
• Journal / source: NICE (UK) (2020)
• Design: Clinical practice guideline (UK)
• Sample: National guideline
• Primary endpoint: —
• Randomized: No · Sham/placebo-controlled: No · Independent of the manufacturer: Yes

What this research found

Amplification: OFFER with hearing loss affecting communication; CONSIDER with hearing loss without communication difficulty; DO NOT OFFER without hearing loss. Psychological therapies (stepped): digital tinnitus-related CBT → group interventions (MBCT/ACT/CBT) → individual CBT. Betahistine: 'Do not offer betahistine to treat tinnitus.' Sound therapy and neuromodulation: 'We were unable to make recommendations for practice in this area.'

Also advises against psychoacoustic pitch/loudness matching for assessment. Read from the official NICE pathway document (NBK557037 mirror). NICE's sound-therapy position (no practice recommendation) conflicts with AAO-HNSF's 'option' — shown as a disagreement, not resolved by this platform.

Limitations and conflicts of interest

UK service context.

Funding / conflicts: National HTA body.

Primary sources

• PubMed record (32437098)
• Source link

Used as evidence for

• Cognitive Behavioral Therapy (CBT)
• Digital CBT & app-based therapeutics
• Hearing aids (with hearing loss)
• Sound therapy & masking